Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Diagnostic or test agent produces in vivo fluorescence
Reexamination Certificate
2011-01-25
2011-01-25
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Diagnostic or test agent produces in vivo fluorescence
C424S001110, C424S001650, C424S009100, C206S223000, C206S569000, C544S101000
Reexamination Certificate
active
07875261
ABSTRACT:
The invention provides novel fluorinated resorufin compounds that are of use in a variety of assay formats. Also provided are methods of using the compounds and kits that include a compound of the invention and instructions detailing the use of the compound in one or more assay formats.
REFERENCES:
patent: 4384042 (1983-05-01), Miike et al.
patent: 4420568 (1983-12-01), Wang et al.
patent: 4510251 (1985-04-01), Kirkemo et al.
patent: 4711955 (1987-12-01), Ward et al.
patent: 4719097 (1988-01-01), Muhlegger et al.
patent: 4737466 (1988-04-01), Klein et al.
patent: 4954630 (1990-09-01), Klein et al.
patent: 4997928 (1991-03-01), Hobbs
patent: 5047519 (1991-09-01), Hobbs, et al.
patent: 5049673 (1991-09-01), Tsien et al.
patent: 5171534 (1992-12-01), Smith et al.
patent: 5208148 (1993-05-01), Haugland et al.
patent: 5304645 (1994-04-01), Klein et al.
patent: 5332666 (1994-07-01), Prober et al.
patent: 5352803 (1994-10-01), Mattingly
patent: 5362628 (1994-11-01), Haugland et al.
patent: 5405975 (1995-04-01), Kuhn et al.
patent: 5453517 (1995-09-01), Kuhn et al.
patent: 5459268 (1995-10-01), Haugland et al.
patent: 5573904 (1996-11-01), Mattingly
patent: 5576424 (1996-11-01), Mao et al.
patent: 5648270 (1997-07-01), Kuhn et al.
patent: 5686261 (1997-11-01), Zhang et al.
patent: 5714327 (1998-02-01), Houthoff et al.
patent: 6972339 (2005-12-01), Lukhtanov et al.
patent: 7432372 (2008-10-01), Batchelor et al.
patent: 0115394 (1984-08-01), None
patent: 0138481 (1991-06-01), None
patent: 2360846 (2001-10-01), None
patent: WO-2003/023357 (2003-03-01), None
patent: WO-03023357 (2003-03-01), None
patent: WO-05042504 (2005-05-01), None
U.S. Appl. No. 10/980,139, “Final Rejection mailed Jul. 16, 2007”.
U.S. Appl. No. 10/980,139, “Non-Final Rejection, mailed Jan. 29, 2008”.
U.S. Appl. No. 10/980,139, “Non-Final Rejection, mailed Mar. 2, 2007”.
U.S. Appl. No. 10/980,139, “Notice of Allowance, mailed May 30, 2008”.
U.S. Appl. No. 10/980,139, “Response to Jan. 29, 2008 Non-Final Office Action, filed Mar. 28, 2008”.
U.S. Appl. No. 10/980,139, “Response to Mar. 2, 2007 Non-Final Rejection, filed Jun. 28, 2007”.
U.S. Appl. No. 10/980,139, “Response to Jul. 16, 2007 Final Rejection, filed Jan. 16, 2008”.
U.S. Appl. No. 10/980,139, “Response to Jan. 23, 2007 Restriction Requirement filed Feb. 23, 2007”.
U.S. Appl. No. 10/980,139, “Restriction Requirement mailed Jan. 23, 2007”.
U.S. Appl. No. 10/980,139, “Supplemental Response or Amendment filed Jan. 24, 2008”.
Bouizar, Z. et al., “Purification and Characterization of Calcitonin Receptors in Rat Kidney Membranes by Covalent Cross-Linking Techniques.”,Eur J Biochemvol. 155(1) 1986, pp. 141-147.
Browning, Jeffrey et al., “Studies on the Differing Effects of the Tumor Necrosis Factor and Lymphotoxin on the Growth of Several Human Tumor Lines”,The Journal of Immunologyvol. 143, No. 6 1989, pp. 1859-1867.
Database Beilstein 1999, “Databased Accession No. 8003161 (BRN) 7-(diethylamino)-1, 2-difluoro-phenoxazin-3-one &”,Russian Journal of Physical Chemistryvol. 72, No. 2 1998, 272-276.
Database Caplus Chemical, “Abstracts Service, Columbus, Ohio US; 2002”,Database Accession No. 2002:257217 RN 204519-58-4, 439869-32-6&Materials Research Society Symposium Proceedingsvol. 677 2001, AA& 4 1 - AA7 4 6.
Database Caplus Chemical, “Chemical Abstracts Service”, Columbus, Ohio US; 1982, Database Accession No. 1982:20048 RN 80287-45-2 & lzvestiya Sibirskogo Otdeleniya Akedemii Nauk SSSR, SeriyaSome Reactions of 10-Phenyloctafluorophenothiazine and its Oxide96:20048 5: 1981, 125-129.
EP04810240.4, “European Office Action, mailed Mar. 2, 2010”.
EP04810240.4, “European Office Action, mailed Dec. 3, 2208”.
EP04810240.4, “Response to Dec. 3, 2008 European Office action filed on Jun. 10, 2009.”.
Furniss, Brian S. et al., “Resolution of Racemates”,Vogel's Textbook of Practical Organic ChemistryFifth Ed, Longman Group UK Ltd., Essex 1989, 809-823.
Gerasimova, T. N. et al., “Synthesis of Fluorinated 7-Diethylaminophenoxazin-3-ones and 9-Diethylamino-5H-Benzo[a]Phenoxazine5-Ones”,Russ. Journal of Org. Chemvol. 33 1997, 735-739.
Haugland, Rosaria P., “Ch 22: Coupling of monoclonal antibodies with fluorophores”,Methods in Molecular Biologyvol. 45: Monoclonal Antibody Protocols 1995, 205-221.
Heller, A., “Electrical Wiring of Redox Enzymes”,Acc. Chem. Res.vol. 23, No. 5 1990, 128-134.
Jung, S. M. et al., “Crosslinking of Platelet Glycoprotein lb by N-Succinimidyl (4-azidophenyldithio) Propionate and 3, 3'-dithiobis (Sulfosuccinimidyl Promionate)”,Biochimica et Biophysica Actavol. 761 1983, pp. 152-162.
Park, Linda S. et al., “Characterization of the Cell Surface Receptor for a Multi-Lineage Colony-Stimulating Factor (CSF-2alpha)*”,The Journal of Biological Chemistryvol. 261, No. 1 1986, pp. 205-210.
PCT/US04/36546, “International Report on Patentability, mailed May 1, 2006”.
PCT/US04/36546, “International Search Report”, Mar. 31, 2005.
PCT/US04/36546, “PCT Written Opinion of the International Searching Authority, mailed Apr. 30, 2006”.
Sandler, Stanley R. et al.,Organic Functional Group Preparationsvol. 3, New York: Academic Press 1972, 5-7.
Zarling, David A. et al., “Mapping of Lymphocyte Surface Polypeptide Antigens by Chemical Cross-Linking with BSOCOES”,The Journal of Immunologyvol. 124, No. 2 1980, pp. 913-920.
Batchelor Robert
Ge Yue
Gee Kyle
Johnson Iain
Leung Wai-Yee
Blodgett James K.
Jones D L
Life Technologies Corporation
Life Technologies Corporation
LandOfFree
Fluorinated resorufin compounds and their application does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorinated resorufin compounds and their application, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorinated resorufin compounds and their application will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2685716